Alosachie I., Peter J.B., Tsuchihashi H., Knight D.L., Nemeroff C.B. (1990) Is decreased imipramine binding by platelet membranes in major depression associated with plasma autoantibodies to imipramine binding sites? Biol Psychiatr28: 362-365
2.
Anderson G.M., Stevenson J.M., Cohen D.J. (1987) Steady state model for plasma free and platelet serotonin in man. Life Sci41: 1777-1785
3.
Ashby C.R., Carr L.A., Cook C.L., Steptoe M.M., Franks D.D. (1990) Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome. J Neural Transm [Gen Sect] 79: 41-50
4.
Barbaccia M.L., Karoum F., Costa E. (1985) Characterization of the endocoid for imipramine recognition sites. In Lal H, LaBella F, Lane J (eds), Endocoids. Alan R Liss, New York, pp. 431-440
5.
Barbaccia M.L., Costa E., Guidotti A. (1988) Endogenous ligands for high affinity recognition sites of psychotropic drugs. Annu Rev Pharmacol Toxicol28: 451-476
6.
Briley M., Raisman R., Langer S.Z. (1979) Human platelets possess high affinity binding sites for 3H-imipramine. Eur J Pharmacol58: 347-348
7.
Briley M., Langer S.Z., Raisman R., Sechter D., Zarifian E. (1980) Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science209: 303-305
8.
Butler J., Leonard BE (1990) Comparison of mianserin and dothiepin treatment on the serotonergic system of depressed patients. Human Psychopharmacol5: 369-372
9.
DeClerck F., Xhonneaux B., Leysen J., Janssen P A J (1984) Evidence for functional 5-HT2 receptor sites on human blood platelets. Biochem Pharmacol17: 2807-2811
10.
Goto S., Egashira T., Yamanaka Y. (1991) Evidence for the existence of serotonin uptake inhibitor-like substances in human cerebrospinal fluid. Jap J Pharmacol56: 297-302
11.
Healy D., Carney P.A., O'Halloran A., Leonard B.E. (1985) Peripheral adrenoceptors and serotonin receptors in depression; changes associated with response to treatment with trazodone or amitryptyline. J Affective Disord9: 285-296
12.
Healy D., Calvin J., Whitehouse A.M., White W., Wilton-Cox H., Theodoron A.E., Lawrence K.M., Horton R.W., Paykel E.S. (1991) Alpha-1-acid glyco-proteins in major depressive and eating disorders. J Affective Disord22:13-20
13.
Huttunen P., Spencer B.A., Meyers R.D. (1985) Monoamine transmitter release induced by tetrahydro-β-carboline perfused in hippocampus of the unrestrained rat. Brain Res Bull15: 215-220
14.
Langer S.Z., Lee C.R., Segonzac A., Tateishi T., Esnaud H., Shoemaker H., Winblad B. (1984) Possible endocrine role of the pineal gland for 6 methoxytetrahydro-beta-carboline : a putative endogenous neuromodulator of the 3H-imipramine recognition site. Eur J Pharmacol102: 379-380
15.
Leonard B.E. (1991) Blood cells as models of neurons: studies in the affective disorders. J Ir Coll Physicians Surg20: 282-284
16.
Leysen J.E. (1985) Characterization of serotonin receptor binding sites. In Green A R (ed.), Neuropharmacology of serotonin. Oxford University Press , pp. 79-116
17.
Lingjaerde O. (1977) Platelet uptake and storage of serotonin. In Essman W B (ed.), Serotonin in health and disease. Vol 4. Spectrum, New York, pp. 139-199
18.
McAdams C., Colohan F.J., Brophy I., Leonard B.E. (1992) Alteration by a plasma factor of platelet aggregation and 5HT uptake in depression. Biol Psychiatr32: 296-298
19.
Mellerup E., Plenge P. (1986) High affinity binding of 3H-paroxetine and 3H-imipramine to human platelet membranes. Eur J Pharmacol96: 303-309
20.
Mir M.A. (1988) Difficulties in the isolation and identification of endogenous ouabain-like substances. Prog Biochem Pharmacol23: 1-9
21.
Nemeroff C.B., Krishnan R.R., Blazer D.G., Knight D.L., Benjamin D., Meyerson L.R. (1990) Elevated plasma concentrations of alpha1-acid glycoprotein, a putative endogenous inhibitor of the tritiated imipramine binding site in depressed patients. Arch Gen Psychiatr47: 337-340
22.
Paul S.M., Rehavi M., Skolnick P., Ballenger J.C., Goodwin F.K. (1981) Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter". Arch Gen Psychiatr30: 1315-1317
Plenge P., Mellerups E.T., Laursen H. (1990) Regional distribution of the serotonin transport complex in human brain identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine . Prog Neuropsychopharmacol Biol Psychiatr14: 72-81
25.
Pletscher A., Affolter H. (1983) The 5-hydroxytryptamine receptor of blood platelets . J Neural Transm57: 233-242
26.
Raisman R., Briley M., Langer S.Z. (1979) Specific tricyclic antidepressant binding sites in rat brain. Nature281: 148-150
27.
Roth B.L., Nakaki T., Chuang D.M., Costa E. (1985) Evidence for an endocoid for the 5-HT2 recognition site. Prog Clin Biol Res192: 473-476
28.
Skolnick P., Crawley J.N., Glowa J.R., Paul S. ( 1984) Beta-carboline induced anxiety state. Psychopathology17 (Suppl 3): 52-60
29.
Tang S.W., Cheung S., Strijewski A., Chudzik J., Helmeste D. (1990) Anti-imipramine antibodies recognize endogenous serotonin uptake and imipramine binding inhibitors. Psychiatr Res34:205-212
30.
Tuomisto J., Tukianien E. (1976) Decreased uptake of 5-hydroxytryptamine in blood platelets from depressed patients. Nature262: 596-598
